The Latest Breaking News from BTIG

Upgrades

Upgrades

 

BTIG analyst Peter Saleh reduced the price target on Starbucks Corp (NASDAQ:SBUX) to $110 from $130 and kept a buy rating on the shares. The revised price target implies a 37% upside. The analyst also cut his FY22 and FY23 earnings estimates after factoring in the uncertainty of unionization, the high probability of wage and…

The news of Apple Inc (NASDAQ:AAPL) developing payment-processing technology to bring some of its financial-services offerings in-house triggered a meltdown in CoreCard Corp (NYSE:CCRD) share prices.  However, BTIG analyst Mark Palmer views the pressure on CoreCard shares as vivid. He sees it as unlikely that Apple's move to bring more of its payment processing in-house would…

BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.

BTIG analyst Carl Reichardt downgraded LGI Homes (NASDAQ:LGIH) to Sell from Neutral with a $98 price target, implying an 11% downside. Carl showed concern about the company’s reliance on single-family rental investors for delivery volume and the impact of higher rates on those customers. The analyst thinks that LGI has a higher demand risk profile…

BTIG analyst Gray Powell initiated coverage of Datadog Inc (NASDAQ:DDOG) with a Buy rating and $175 price target (24.9% upside).  Powell saw the observability market benefiting over the next few years as companies increasingly invest in digital transformation initiatives. Powell saw Datadog "winning across multiple product categories."  Powell's checks indicate Datadog as the most innovative…

BTIG upgraded Implantable lenses-focused Staar Surgical Company (NASDAQ: STAA) to Buy from Neutral with a $98 price target.